Jove
Visualize
Contact Us

Related Concept Videos

Classification of Leukocytes01:30

Classification of Leukocytes

3.5K
Leukocytes are classified into two groups based on the presence or absence of cytoplasmic granules. Granular leukocytes, which contain granules, belong to the myeloid lineage and are divided into three subtypes: neutrophils, eosinophils, and basophils. These cells are roughly spherical and characterized by the granules in their cytoplasm.
Neutrophils are the most abundant type of granular leukocytes, comprising 50-70% of all leukocytes. They feature small, evenly distributed granules and a...
3.5K
Disorders of Leukocytes01:27

Disorders of Leukocytes

1.2K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.2K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

292
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
292
Glucose Transporters01:27

Glucose Transporters

25.5K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
25.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis of NK-Large Granular Lymphocytic Leukemia.

Blood advances·2026
Same author

<i>CEBP</i> and <i>ZEB2</i> alterations define three distinct subtypes of B-cell acute lymphoblastic leukemia.

HemaSphere·2026
Same author

Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacterales bacteraemia in high-risk neutropenic patients in haematology: A multicentre retrospective study.

International journal of antimicrobial agents·2026
Same author

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same author

Signals from the bone marrow B cell niches shape pre-leukemic fate in a murine model of B cell acute lymphoblastic leukemia.

Oncogene·2026
Same author

Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.

Blood·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Oct 3, 2025

qKAT: Quantitative Semi-automated Typing of Killer-cell Immunoglobulin-like Receptor Genes
07:58

qKAT: Quantitative Semi-automated Typing of Killer-cell Immunoglobulin-like Receptor Genes

Published on: March 6, 2019

8.7K

Toward a Better Classification System for NK-LGL Disorders.

Gaëlle Drillet1, Cédric Pastoret2, Aline Moignet1

  • 1Service d'Hématologie Clinique, Centre Hospitalier Universitaire de Rennes, Rennes, France.

Frontiers in Oncology
|February 18, 2022
PubMed
Summary

Large granular lymphocytic leukemia involves T or natural killer (NK) cells. Recent mutation discoveries aid in diagnosing this rare disorder, guiding treatment strategies for affected patients.

Keywords:
KIR phenotypeNK cellsSTAT3chronic lymphoproliferative disorders of NK cellslarge granular lymphocyte leukemia

More Related Videos

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
05:24

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia

Published on: February 21, 2021

4.3K
A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity
06:08

A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity

Published on: August 9, 2017

24.3K

Related Experiment Videos

Last Updated: Oct 3, 2025

qKAT: Quantitative Semi-automated Typing of Killer-cell Immunoglobulin-like Receptor Genes
07:58

qKAT: Quantitative Semi-automated Typing of Killer-cell Immunoglobulin-like Receptor Genes

Published on: March 6, 2019

8.7K
Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
05:24

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia

Published on: February 21, 2021

4.3K
A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity
06:08

A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity

Published on: August 9, 2017

24.3K

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Large granular lymphocytic leukemia (LGLL) is a rare lymphoproliferative disorder.
  • It involves clonal expansion of T-cell or natural killer (NK) cells.
  • LGLL often presents with cytopenia and autoimmune conditions.

Purpose of the Study:

  • To review the pathophysiology of NK-cell LGLL.
  • To discuss recent diagnostic advancements.
  • To explore current and emerging therapeutic strategies.

Main Methods:

  • Review of existing literature on LGLL pathophysiology.
  • Analysis of recent findings on recurrent mutations in LGLL.
  • Synthesis of diagnostic and therapeutic approaches.

Main Results:

  • Distinguishing clonal from reactive NK-cell expansion is challenging.
  • Recurrent mutations offer new tools for proving clonality.
  • Two-thirds of patients eventually require treatment.

Conclusions:

  • Understanding LGLL pathogenesis is evolving with mutation discoveries.
  • Improved diagnostic tools are crucial for accurate classification.
  • Tailored therapeutic strategies are essential for managing LGLL.